162
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Omalizumab for Severe Allergic Asthma Treatment in Italy: A Cost-Effectiveness Analysis from PROXIMA Study

, ORCID Icon, ORCID Icon, , , , ORCID Icon & ORCID Icon show all
Pages 43-53 | Published online: 22 Jan 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Sajesh K. Veettil, Vanessa Vincent, Taylor Shufelt, Emma Behan, M. Sakil Syeed, Ammarin Thakkinstian, David C. Young & Nathorn Chaiyakunapruk. (2023) Incremental net monetary benefit of biologic therapies in moderate to severe asthma: a systematic review and meta-analysis of economic evaluation studies. Journal of Asthma 60:9, pages 1702-1714.
Read now
Sara Alves, João Cavaleiro Rufo & José Crispim. (2023) Economic evaluation of biological treatments in patients with severe asthma: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research 23:7, pages 733-747.
Read now
Jeffrey P Aldinger, Taylor Dobyns, Kent Lam & Joseph K Han. (2021) The role of omalizumab in the treatment of chronic rhinosinusitis with nasal polyposis. Expert Opinion on Biological Therapy 21:9, pages 1143-1149.
Read now

Articles from other publishers (8)

Katie Bitting, Barry Hedgespeth, Lauren C. Ehrhardt‐Humbert, Greer K. Arthur, Alicia G. Schubert, Peter Bradding, Stephen L. Tilley & Glenn Cruse. (2022) Identification of redundancy between human FcεRIβ and MS4A6A proteins points toward additional complex mechanisms for FcεRI trafficking and signaling . Allergy 78:5, pages 1204-1217.
Crossref
V. V. Naumova, Е. К. Beltyukov, V. Ch. Abdullaev, A. U. Petukhova, A. A. Shtanova & D. A. Stepina. (2023) Efficacy of two-year anti-IgE therapy in patients with severe allergic bronchial asthma in Sverdlovsk region. Meditsinskiy sovet = Medical Council:4, pages 8-17.
Crossref
María Nieto‐Cid, Teresa Garriga‐Baraut, Ana Mª. Plaza‐Martín, Miguel Tortajada‐Girbés, Javier Torres‐Borrego, Jaime Lozano‐Blasco, Laura Moreno‐Galarraga, Mª. del Mar Folqué‐Giménez, Montse Bosque‐García, Mirella Gaboli, Alejandro López‐Neyra, Cristina Rivas‐Juesas, Mª. Araceli Caballero‐Rabasco, Andrea Freixa‐Benavente, Laura Valdesoiro‐Navarrete, Inés de Mir‐Messa, Esther Ballester‐Asensio, María Penín‐Antón, Raquel Romero‐García, Juan Navarro‐Morón, Alfredo Valenzuela‐Soria, Mercedes Sánchez‐Mateos, José Batlles‐Garrido, Verónica Sanz‐Santiago, Álvaro Gimeno‐Díaz de Atauri, Anselmo Andrés‐Martín, Elena Campos‐Alonso, David Gómez‐Pastrana, Elena Vázquez‐Rodríguez, Luz Martínez‐Pardo, Genoveva del Río‐Camacho, Ángel Mazón‐Ramos & Antonio Nieto‐García. (2023) Cost‐effectiveness of omalizumab for the treatment of severe pediatric allergic asthma—Results of a real‐life study in Spain . Pediatric Allergy and Immunology 34:4.
Crossref
Paola Faverio, Raffaella Ronco, Matteo Monzio Compagnoni, Matteo Franchi, Giovanni Franco, Giulia Bonaiti, Martina Bonifazi, Federico Mei, Fabrizio Luppi, Alberto Pesci & Giovanni Corrao. (2023) Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study. Respiratory Research 24:1.
Crossref
Danilo Di Bona, Federico Spataro, Palma Carlucci, Giovanni Paoletti & Giorgio W. Canonica. (2022) Severe asthma and personalized approach in the choice of biologic. Current Opinion in Allergy & Clinical Immunology 22:4, pages 268-275.
Crossref
Min Zhang, Meiling Jin, Xin Zhou, Jiangtao Lin, Xiansheng Liu, Chuntao Liu, Mao Huang, Wen Wang, Liang Chen, Yijiang Huang, Jing Li, Qingling Zhang, Huahao Shen, Yali Yu, Wei Tang, Jianying Zhou, Hongju Liu, Liang Dong, Yan Hu, Hua Wu, Yanhong Li, Weidong Song, Ming Ouyang, Xiaoling Yuan, Tao Wang & Shengdao Xiong. (2021) Effectiveness of omalizumab in patients with severe allergic asthma: A retrospective study in China. Respiratory Medicine 186, pages 106522.
Crossref
Nan Wang, Jue Wang, Yongjing Zhang, Yingnan Zeng, Shiling Hu, Haoyun Bai, Yajing Hou, Cheng Wang, Huaizhen He & Langchong He. (2021) Imperatorin ameliorates mast cell-mediated allergic airway inflammation by inhibiting MRGPRX2 and CamKII/ERK signaling pathway. Biochemical Pharmacology 184, pages 114401.
Crossref
Syed Shahzad Hasan, Toby Capstick, Syed Tabish Razi Zaidi, Chia Siang Kow & Hamid A. Merchant. (2020) Use of corticosteroids in asthma and COPD patients with or without COVID-19. Respiratory Medicine 170, pages 106045.
Crossref